5WDJ
CRYSTAL STRUCTURE OF MYELOPEROXIDASE SUBFORM C (MPO) COMPLEX WITH COMPOUND-6 AKA 7-(BENZYLOXY)-1H-[1,2, 3]TRIAZOLO[4,5-D]PYRIMIDIN-5-AMINE
Summary for 5WDJ
Entry DOI | 10.2210/pdb5wdj/pdb |
Descriptor | Myeloperoxidase, alpha-L-fucopyranose, alpha-D-mannopyranose, ... (12 entities in total) |
Functional Keywords | myeloperoxidase, metal binding protein |
Biological source | Homo sapiens (Human) More |
Total number of polymer chains | 4 |
Total formula weight | 135605.64 |
Authors | Khan, J.A. (deposition date: 2017-07-05, release date: 2018-04-18, Last modification date: 2020-07-29) |
Primary citation | Duclos, F.,Abell, L.M.,Harden, D.G.,Pike, K.,Nowak, K.,Locke, G.A.,Duke, G.J.,Liu, X.,Fernando, G.,Shaw, S.A.,Vokits, B.P.,Wurtz, N.R.,Viet, A.,Valente, M.N.,Stachura, S.,Sleph, P.,Khan, J.A.,Gao, J.,Dongre, A.R.,Zhao, L.,Wexler, R.R.,Gordon, D.A.,Kick, E.K. Triazolopyrimidines identified as reversible myeloperoxidase inhibitors. Medchemcomm, 8:2093-2099, 2017 Cited by PubMed: 30108726DOI: 10.1039/c7md00268h PDB entries with the same primary citation |
Experimental method | X-RAY DIFFRACTION (2.4 Å) |
Structure validation
Download full validation report